UB Paderborn / Katalog / Suche / in CDI

A limited number of antibody specificities mediate broad and potent serum neutralization in selected HIV-1 infected individuals

PLoS pathogens, 2010-08, Vol.6 (8), p.e1001028-e1001028

2010

Link zum Volltext

Verfügbarkeit prüfen

Broad and Potent Neutralizing Antibodies from an African Donor Reveal a New HIV-1 Vaccine Target

Science (American Association for the Advancement of Science), 2009-10, Vol.326 (5950), p.285-289

2009

Link zum Volltext

Verfügbarkeit prüfen

Structure and function of broadly reactive antibody PG16 reveal an H3 subdomain that mediates potent neutralization of HIV-1

Proceedings of the National Academy of Sciences - PNAS, 2010-06, Vol.107 (25), p.11483-11488

2010

Link zum Volltext

Verfügbarkeit prüfen

Broadly Cross-Reactive HIV-1-Neutralizing Human Monoclonal Fab Selected for Binding to gp120-CD4-CCR5 Complexes

Proceedings of the National Academy of Sciences - PNAS, 2002-05, Vol.99 (10), p.6913-6918

2002

Link zum Volltext

Verfügbarkeit prüfen

Evidence for CD4-enchanced Signaling through the Chemokine Receptor CCR5

The Journal of biological chemistry, 2003-03, Vol.278 (12), p.10389-10392

2003

Link zum Volltext

Verfügbarkeit prüfen

The stem of vesicular stomatitis virus G can be replaced with the HIV-1 Env membrane-proximal external region without loss of G function or membrane-proximal external region antigenic properties

AIDS research and human retroviruses, 2014-11, Vol.30 (11), p.1130

2014

Link zum Volltext

Verfügbarkeit prüfen

HIV-1 rational vaccine design: molecular details of b12-gp120 complex structure

Expert review of vaccines, 2007-06, Vol.6 (3), p.319-321

2007

Link zum Volltext

Verfügbarkeit prüfen

Cell biology of virus entry: a review of selected topics from the 3rd International Frederick meeting

BBA - Biomembranes, 2003-07, Vol.1614 (1), p.85-88

2003

Link zum Volltext

Verfügbarkeit prüfen

A Limited Number of Antibody Specificities Mediate Broad and Potent Serum Neutralization in Selected HIV-1 Infected Individuals: e1001028

PLoS pathogens, 2010-08, Vol.6 (8)

2010

Link zum Volltext

Verfügbarkeit prüfen

Broadly cross-reactive HIV-1-neutralizing human monoclonal Fab selected for binding to gp 120-CD4-CCR5 complexes

Proceedings of the National Academy of Sciences - PNAS, 2002-05, Vol.99 (10), p.6913

2002

Link zum Volltext

Verfügbarkeit prüfen

On the estimation of number of events required for saturation mutagenesis of large genomes

Current science (Bangalore), 2001-04, Vol.80 (7), p.823-824

2001

Link zum Volltext

Verfügbarkeit prüfen

Analysis of Neutralization Specificities in Polyclonal Sera Derived from Human Immunodeficiency Virus Type 1-Infected Individuals

Journal of Virology, 2009-01, Vol.83 (2), p.1045-1059

2009

Link zum Volltext

Verfügbarkeit prüfen

Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9

Nature (London), 2011-12, Vol.480 (7377), p.336-343

2011

Link zum Volltext

Verfügbarkeit prüfen

A Randomized, Double-Blinded, Placebo-Controlled, Phase 1 Study of a Replication-Defective Herpes Simplex Virus (HSV) Type 2 Vaccine, HSV529, in Adults With or Without HSV Infection

The Journal of infectious diseases, 2019-08, Vol.220 (6), p.990-1000

2019

Link zum Volltext

Verfügbarkeit prüfen

Functional diversity and behavioral changes of microbial communities under salt affected soils

Applied soil ecology : a section of Agriculture, ecosystems & environment, 2023-10, Vol.190, p.105017, Article 105017

2023

Link zum Volltext

Verfügbarkeit prüfen

Immunotypes of a Quaternary Site of HIV-1 Vulnerability and Their Recognition by Antibodies

Journal of Virology, 2011-05, Vol.85 (9), p.4578-4585

2011

Link zum Volltext

Verfügbarkeit prüfen

Simulation of salt and water movement and estimation of water productivity of rice crop irrigated with saline water

Paddy and water environment, 2010-12, Vol.8 (4), p.333-346

2010

Link zum Volltext

Verfügbarkeit prüfen

Crystal Structure of Human Antibody 2909 Reveals Conserved Features of Quaternary Structure-Specific Antibodies That Potently Neutralize HIV-1

Journal of Virology, 2011-03, Vol.85 (6), p.2524-2535

2011

Link zum Volltext

Verfügbarkeit prüfen

HIV type 1 Env precursor cleavage state affects recognition by both neutralizing and nonneutralizing gp41 antibodies

AIDS research and human retroviruses, 2011-08, Vol.27 (8), p.877

2011

Link zum Volltext

Verfügbarkeit prüfen

Modulation of DNA/ALVAC/gp120 vaccine immune-response by vaccination with Insulin-Like Growth Factor 1 (IGF-1)

The Journal of immunology (1950), 2017-05, Vol.198 (1_Supplement), p.225-225.17

2017

Link zum Volltext

Verfügbarkeit prüfen

Network design for groundwater level monitoring in Upper Bari Doab Canal tract, Punjab, India

Irrigation and drainage, 2005-10, Vol.54 (4), p.431-442

2005

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

A limited number of antibody specificities mediate broad and potent serum neutralization in selected HIV-1 infected individuals

Broad and Potent Neutralizing Antibodies from an African Donor Reveal a New HIV-1 Vaccine Target

Structure and function of broadly reactive antibody PG16 reveal an H3 subdomain that mediates potent neutralization of HIV-1

Broadly Cross-Reactive HIV-1-Neutralizing Human Monoclonal Fab Selected for Binding to gp120-CD4-CCR5 Complexes

Evidence for CD4-enchanced Signaling through the Chemokine Receptor CCR5

The stem of vesicular stomatitis virus G can be replaced with the HIV-1 Env membrane-proximal external region without loss of G function or membrane-proximal external region antigenic properties

HIV-1 rational vaccine design: molecular details of b12-gp120 complex structure

Cell biology of virus entry: a review of selected topics from the 3rd International Frederick meeting

A Limited Number of Antibody Specificities Mediate Broad and Potent Serum Neutralization in Selected HIV-1 Infected Individuals: e1001028

Broadly cross-reactive HIV-1-neutralizing human monoclonal Fab selected for binding to gp 120-CD4-CCR5 complexes

On the estimation of number of events required for saturation mutagenesis of large genomes

Analysis of Neutralization Specificities in Polyclonal Sera Derived from Human Immunodeficiency Virus Type 1-Infected Individuals

Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9

Pentavalent HIV-1 vaccine protects against simian-human immunodeficiency virus challenge

A Randomized, Double-Blinded, Placebo-Controlled, Phase 1 Study of a Replication-Defective Herpes Simplex Virus (HSV) Type 2 Vaccine, HSV529, in Adults With or Without HSV Infection

Functional diversity and behavioral changes of microbial communities under salt affected soils

Immune correlates of the Thai RV144 HIV vaccine regimen in South Africa

Immunotypes of a Quaternary Site of HIV-1 Vulnerability and Their Recognition by Antibodies

Simulation of salt and water movement and estimation of water productivity of rice crop irrigated with saline water

Crystal Structure of Human Antibody 2909 Reveals Conserved Features of Quaternary Structure-Specific Antibodies That Potently Neutralize HIV-1

HIV type 1 Env precursor cleavage state affects recognition by both neutralizing and nonneutralizing gp41 antibodies

Vaccine-Induced Linear Epitope-Specific Antibodies to Simian Immunodeficiency Virus SIVmac239 Envelope Are Distinct from Those Induced to the Human Immunodeficiency Virus Type 1 Envelope in Nonhuman Primates

Comparison of Immunogenicity in Rhesus Macaques of Transmitted-Founder, HIV-1 Group M Consensus, and Trivalent Mosaic Envelope Vaccines Formulated as a DNA Prime, NYVAC, and Envelope Protein Boost

Modulation of DNA/ALVAC/gp120 vaccine immune-response by vaccination with Insulin-Like Growth Factor 1 (IGF-1)

Network design for groundwater level monitoring in Upper Bari Doab Canal tract, Punjab, India

Suchergebnisse filtern